{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Toxicity post ALI infusion"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Toxicity post Rev maintenance"}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"description":"Time frame includes after stem cell transplant engraftment. Toxicity post ALI infusion: 1 patient grade 1 hypertension 90 min post infusion. Toxicity post Rev maintenance: 1 patient not tolerated, 1 patient dose decreased due to counts.","groups":[{"description":"azacitidine: 75 mg/sq m daily for 5 days\n\nlenalidomide: 10 mg p.o. daily, Days 6-21","id":"OG000","title":"5-azacytidine + Lenalidomide -> Auto Stem Cell Transplant"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"6 months","title":"Toxicity as Assessed by NCI CTCAE v3.0","type":"SECONDARY","unitOfMeasure":"participants"}